Tech Company Financing Transactions
AbSci Funding Round
On 3/8/2021, AbSci raised investment from Merck Capital Ventures.
Transaction Overview
Company Name
Announced On
3/8/2021
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Merck Capital Ventures (Prem Tumkosit)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
101 E 6th St. 350
Vancouver, WA 98660
USA
Vancouver, WA 98660
USA
Phone
Website
Email Address
Overview
AbSci is a global leader in cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sean McClain
Chief Financial Officer
Gregory Schiffman
Chief Operating Officer
Andrew Pihl
Chief Technical Officer
Matthew Weinstock
VP - General Counsel
Lawrence McClure
Browse more venture capital transactions:
Prev: 3/8/2021: Fillogic venture capital transaction
Next: 3/8/2021: Spark Advisors venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs